Pulling SEC filings + quote and writing the call…

Modular Medical, Inc.
Next earnings Aug 12, 2026 · consensus $-0.10 EPS, $204K rev
Conservative balance sheet (liabilities/equity 0.10x).
Revenue (FY2018) $0.00 · FY2018
Modular Medical, Inc. shows $0.00 in FY2018 revenue, and -110.2% ROE.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$7.34M | -$14.9M | -$13.9M | -$17.5M | -$19.0M |
| Net income | -$7.38M | -$18.6M | -$13.9M | -$17.5M | -$18.8M |
| Diluted EPS | — | -$2.74 | -$1.15 | -$0.78 | -$0.51 |
| Net margin | — | — | — | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Sources: SEC EDGAR (CIK 0001074871, latest 10-Q filed 2026-02-17) · EODHD · as of 6/26/2026, 1:09:55 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2026-03-31 | FELSHER STEVEN G Director | Award | 25.00 | |
| 2026-03-31 | DeSisto Duane M Director | Award | 83.00 |
1044 tracked peers · median